Basic Information
Basic information for AL133325.2-202-51aa
Peptide Name AL133325.2-202-51aa
Genome Position chr20:21534953-21535105[+]
Species Human
Peptide Sequence MNYFQALSAVSYCLSFPLAASWKRTSACLGLEFLLLTAARVAICAHIEHIF
Peptide Length 51
Unique Yes
Grand Average of Hydropathicity 0.8804
Relative Molecular Mass 6550.44
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000233492;AL133325.2
Transcript ID/Name ENST00000671531;AL133325.2-202
Transcript Length 1744
Coding Ability 0.4948
DNA Sequence Corresponding to Peptide ATGAATTATTTCCAGGCATTGTCTGCAGTGTCATATTGCTTGAGCTTTCCGTTAGCAGCTTCCTGGAAAAGAACTTCTGCTTGTCTGGGTCTTGAGTTTCTGTTGCTTACAGCAGCCAGAGTTGCCATCTGTGCACATATAGAGCATATATTT
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :